Burden of rheumatoid arthritis from a societal perspective: A prevalence‐based study on cost of this illness for patients in China-Reference-Cited by-同舟云学术

Burden of rheumatoid arthritis from a societal perspective: A prevalence‐based study on cost of this illness for patients in China

Published:2017-02-17 Issue:8 Volume:21 Page:1572-1580
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Hu Hao¹,Luan Luan¹,Yang Keqin²,Li Shu‐Chuen¹

Affiliation:

1. University of Newcastle Callaghan New South Wales Australia

2. Department of Rheumatology Taizhou No.4 Renmin Hospital Taizhou China

Funder

China Scholarship Council

University of Newcastle Australia

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.13028

Reference23 articles.

1. Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013;Global Buerden of Disease Study;Lancet,2013

2. Estimating the cost of illness.

3. China Health Statistical Yearbook(2012)Beijing: Chinese Center for Disease Control and Prevention 2012.

4. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

5. Societal Costs of Rheumatoid Arthritis in China: A Hospital-Based Cross-Sectional Study

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New and Emerging Therapies: Review the Latest Advancements in Rheumatology Treatments, Including Biologic Therapies, Targeted Therapies, Regenerative Medicine, and Novel Drug Development, Assessing their Potential Benefits and Limitations;Journal of Community Pharmacy Practice;2024-08-12

2. Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H;Clinical Immunology;2024-04

3. Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open‐label, randomized‐controlled trial;International Journal of Rheumatic Diseases;2024-01

4. Advancing rheumatic disease treatment: A journey towards better lives;Open Health;2024-01-01

5. The Effectiveness of Telemedicine in Patients with Rheumatoid Arthritis: An Overview of Systematic Reviews and Meta-Analysis;Telemedicine and e-Health;2023-12-01